MRNS delays p2 PPD readout for IV Ganaxolone to Q3’18, increases enrollment. This is the second delay (originally scheduled for Dec ‘17, then pushed to early ‘18). Oral Ganax PPD trial readout in Q4’18.
Is Ganax a dud? Maybe. But to be fair SAGE-217 results were pushed 6 months to increase N too recently. SAGE-517 p2 results could have been an outlier as p3 wasn’t as good as p2. Anyway, I’m out of MRNS for now.
News 
Market Data 
Discover 
AI
